IDEXX Laboratories, Inc. (IDXX) financial statements (2021 and earlier)

Company profile

Business Address ONE IDEXX DRIVE
WESTBROOK, ME 04092-2041
State of Incorp. DE
Fiscal Year End December 31
SIC 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments38490124472392343323
Cash and cash equivalents38490124188155129323
Short-term investments   284237214 
Receivables331269249235204188152
Inventory, net of allowances, customer advances and progress billings210195173164158189160
Inventory210195173164158189160
Prepaid expense      33
Deferred costs      11
Other current assets138125108101916286
Other undisclosed current assets     40(6)
Total current assets:1,063680654972846822759
Noncurrent Assets
Operating lease, right-of-use asset9181
Property, plant and equipment555534437379357333304
Intangible assets, net (including goodwill)296298256244224235250
Goodwill243240214200178179184
Intangible assets, net (excluding goodwill)53584244465665
Prepaid expense      11
Deferred costs      28
Other noncurrent assets2902401901191038572
Other undisclosed noncurrent assets      (39)
Total noncurrent assets:1,2321,153883741685653625
TOTAL ASSETS:2,2951,8321,5371,7131,5311,4751,384
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities490395330320296258344
Accounts payable75727067605345
Accrued liabilities416323261253236206195
Employee-related liabilities      75
Taxes payable      28
Deferred revenue4341
Debt50289399655611573549
Deferred revenue and credits29272632
Contract with customer, liability41
Other undisclosed current liabilities      (104)
Total current liabilities:5837257701,005935857821
Noncurrent Liabilities
Long-term debt and lease obligation936766601606593597350
Long-term debt, excluding current maturities858699601606593597350
Operating lease, liability7767
Liabilities, other than long-term debt143163146157111105101
Deferred revenue and credits36332722
Deferred revenue4649
Contract with customer, liability61
Deferred tax liabilities, net 25394942
Deferred income tax liabilities1233
Other liabilities86818596392932
Business combination, contingent consideration, liability      6
Other undisclosed noncurrent liabilities  29   (6)
Total noncurrent liabilities:1,079929776763704702446
Total liabilities:1,6621,6551,5471,7671,6391,5591,267
Stockholders' equity
Stockholders' equity attributable to parent, including:632177(10)(54)(108)(84)118
Common stock11111110101010
Treasury stock, value(2,800)(2,601)(2,289)(1,912)(1,633)(1,316)(2,453)
Additional paid in capital1,2951,2141,1381,0741,012941888
Accumulated other comprehensive loss(54)(46)(42)(36)(43)(42)(8)
Retained earnings2,1761,5961,1688045403181,675
Other undisclosed stockholders' equity attributable to parent5456655
Stockholders' equity attributable to noncontrolling interest1000000
Total stockholders' equity:633178(9)(54)(108)(84)118
TOTAL LIABILITIES AND EQUITY:2,2951,8321,5371,7131,5311,4751,384

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2,7072,4072,2131,9691,7751,6021,486
Revenue, net1,9691,7751,6021,486
Cost of revenue(1,136)(1,041)(972)(872)(800)(712)(670)
Cost of goods and services sold   (872)(800)(712)(670)
Gross profit:1,5711,3661,2421,097975890816
Operating expenses(877)(813)(750)(684)(625)(590)(616)
Other undisclosed operating income      61
Operating income:695553491413350300260
Nonoperating income (expense)
(Foreign Currency Transaction loss, before Tax)
      (2)
Interest and debt expense(33)(31)(35)(37)(32)(29)(15)
Other undisclosed income from continuing operations before equity method investments, income taxes1015424
Income from continuing operations before income taxes:662522458381322273247
Income tax expense(80)(94)(81)(118)(100)(81)(65)
Net income:582428377263222192182
Net loss attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Net income available to common stockholders, diluted:582428377263222192182

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:582428377263222192182
Other comprehensive income (loss)(7)(4)(5)7(1)(34)(22)
Comprehensive income:575423372270221158160
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)(0)(0)(0)(0)(0)(0)
Comprehensive income, net of tax, attributable to parent:574423372270221158160

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: